PALS1
Basic information
Region (hg38): 14:67240713-67336061
Previous symbols: [ "MPP5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Cerebral palsy;Abnormal facial shape;Intellectual disability;Anxiety;Arachnoid cyst (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PALS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 27 | 33 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 1 | 0 | 29 | 4 | 3 |
Variants in PALS1
This is a list of pathogenic ClinVar variants found in the PALS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-67279202-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
14-67279249-G-A | not specified | Uncertain significance (Nov 09, 2021) | ||
14-67279264-C-T | Atypical Rett syndrome | Uncertain significance (Aug 16, 2021) | ||
14-67279268-G-A | not specified | Uncertain significance (Jun 22, 2024) | ||
14-67279307-G-T | PALS1-related disorder | Uncertain significance (Sep 28, 2022) | ||
14-67279348-C-T | Benign (Oct 19, 2017) | |||
14-67279379-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
14-67279392-GA-G | not specified | Uncertain significance (Jul 24, 2023) | ||
14-67279516-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
14-67292565-C-A | not specified | Likely benign (Jan 17, 2024) | ||
14-67292565-C-T | not specified | Likely benign (Jan 17, 2024) | ||
14-67292567-C-G | not specified | Uncertain significance (Jun 06, 2023) | ||
14-67292655-T-C | not specified | Uncertain significance (Apr 26, 2024) | ||
14-67292668-G-C | not specified | Uncertain significance (Jul 15, 2021) | ||
14-67292699-G-A | not specified | Uncertain significance (Aug 11, 2024) | ||
14-67301408-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
14-67301432-A-C | PALS1-related disorder | Likely benign (Jan 09, 2024) | ||
14-67302051-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
14-67302061-G-C | not specified | Uncertain significance (Aug 15, 2023) | ||
14-67302089-C-T | not specified | Likely benign (Dec 04, 2024) | ||
14-67302101-G-C | not specified | Uncertain significance (Mar 16, 2022) | ||
14-67302402-A-T | Benign (Mar 29, 2018) | |||
14-67302419-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
14-67302440-G-A | not specified | Uncertain significance (Jun 05, 2024) | ||
14-67302458-G-A | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PALS1 | protein_coding | protein_coding | ENST00000261681 | 13 | 94711 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.235 | 0.765 | 125725 | 0 | 22 | 125747 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.41 | 296 | 372 | 0.795 | 0.0000200 | 4481 |
Missense in Polyphen | 98 | 141.33 | 0.69343 | 1707 | ||
Synonymous | -0.969 | 137 | 123 | 1.11 | 0.00000647 | 1213 |
Loss of Function | 4.10 | 8 | 33.7 | 0.238 | 0.00000173 | 423 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000135 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000334 | 0.0000327 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in tight junctions biogenesis and in the establishment of cell polarity in epithelial cells. May modulate SC6A1/GAT1-mediated GABA uptake by stabilizing the transporter. Required for localization of EZR to the apical membrane of parietal cells and may play a role in the dynamic remodeling of the apical cytoskeleton (By similarity). {ECO:0000250}.;
- Pathway
- Tight junction - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);EMT transition in Colorectal Cancer;Tight junction interactions;Cell-cell junction organization;Cell junction organization;Cell-Cell communication
(Consensus)
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- loftool
- 0.451
- rvis_EVS
- 0.47
- rvis_percentile_EVS
- 78.74
Haploinsufficiency Scores
- pHI
- 0.974
- hipred
- Y
- hipred_score
- 0.708
- ghis
- 0.482
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.876
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mpp5
- Phenotype
- hematopoietic system phenotype; normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype;
Zebrafish Information Network
- Gene name
- mpp5a
- Affected structure
- cardiac muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- structure
Gene ontology
- Biological process
- morphogenesis of an epithelial sheet;peripheral nervous system myelin maintenance;myelin assembly;protein localization to myelin sheath abaxonal region;bicellular tight junction assembly;protein localization to plasma membrane;establishment of epithelial cell polarity
- Cellular component
- cytoplasm;plasma membrane;cell-cell adherens junction;bicellular tight junction;endomembrane system;protein-containing complex;myelin sheath adaxonal region;lateral loop;Schmidt-Lanterman incisure;extracellular exosome
- Molecular function
- protein binding;protein domain specific binding